Skip to main content
. 2022 Aug 5;27(2):473–483. doi: 10.1007/s10461-022-03782-7

Table 3.

Risk factors for LTFU among 108 transgender women taking PrEP

Variable n/N (%) Univariable Analysis Multivariable Analysis
HR 95% CI LR P-value aHR 95% CI LR P-value
Age 4.00 0.045* 4.77 0.029*
< 26 (ref.) 13/52 25 1.00 1.00
≥ 26 25/56 45 1.95 1.00–3.81 2.09 1.06–4.14
Syphilis infection 3.98 0.046* 4.14 0.042*
Non-reactive (ref.) 13/49 27 1.00 1.00
Reactive 25/59 42 1.95 1.00–3.81 1.98 1.01–3.88
Frequency of PrEP use 1.13 0.287 1.59 0.207
Daily (ref.) 28/86 33 1.00 1.00
On-demand 10/22 45 1.50 0.73–3.09 1.63 0.78–3.41
Receiving PrEP within lockdown period 0.20 0.652
No (ref.) 35/101 35 1.00
Yes 3/7 43 1.33 0.41–4.31
Relationship status < 0.01 0.999
Single (ref.) 19/58 33 1.00
With a partner 10/28 36 1.00 0.47–2.15
Occupation 0.45 0.800
College student/unemployed 7/15 47 1.43 0.50–4.08
Freelance/self-employed (ref.) 7/20 35 1.00
Employee 11/29 38 1.18 0.46–3.04
History of taking PrEP before participation in the study 4.37 0.036*
Yes (ref.) 4/22 18 1.00
No 34/86 40 2.65 1.00–7.49
Sex worker experience 0.77 0.379
Yes (ref.) 3/13 23 1.00
No 35/95 37 1.64 0.50–5.33
Adverse effects after taking PrEP 0.17 0.677
Yes 8/19 42 1.20 0.52–2.78
No (ref.) 17/46 37 1.00
Feeling anxious after taking PrEP 2.80 0.094
Yes 12/22 55 1.97 0.90–4.33
No (ref.) 13/43 30 1.00
Hormone use 5.37 0.020*
Yes (ref.) 14/48 29 1.00
No 12/18 67 2.56 1.18 − 5.56
Condom use after taking PrEP 2.99 0.084
Yes 19/41 46 2.15 0.86–5.38
No (ref.) 6/24 25 1.00
Able to schedule a timely PrEP follow-up appointment 2.35 0.126
Yes (ref.) 17/50 34 1.00
No 8/15 53 2.00 0.86–4.68

Abbreviations: ref., reference group; HR, hazard ratio; aHR, adjusted hazard ratio; 95%CI, 95% confidence interval; n, number of LTFU participants; N, number of participants; PrEP, pre-exposure prophylaxis; LR, Likelihood Ratio test

*P-value < 0.05